scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/jcheminf/SinghSCAWT12 |
P6179 | Dimensions Publication ID | 1004664384 |
P356 | DOI | 10.1186/1758-2946-4-4 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/1758-2946-4-4 |
P932 | PMC publication ID | 3299594 |
P698 | PubMed publication ID | 22316383 |
P5875 | ResearchGate publication ID | 221816450 |
P50 | author | Anders Wallqvist | Q56419420 |
Mohamed Diwan M AbdulHameed | Q57027586 | ||
P2093 | author name string | Sidhartha Chaudhury | |
Hongmao Sun | |||
Gregory Tawa | |||
Narender Singh | |||
P2860 | cites work | Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups | Q56032354 |
A Quantitative Approach to the Estimation of Chemical Space from a Given Geometry by the Combination of Atomic Species | Q58451370 | ||
Drugs, leads, and drug-likeness: an analysis of some recently launched drugs | Q74210182 | ||
SLIPPER-2001 -- software for predicting molecular properties on the basis of physicochemical descriptors and structural similarity | Q74371619 | ||
Chemical space and biology | Q81153866 | ||
Are there differences between launched drugs, clinical candidates, and commercially available compounds? | Q84067874 | ||
The protein kinase complement of the human genome | Q24324497 | ||
Imidazo[1,2-a]pyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation | Q27641909 | ||
Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885 | Q27643208 | ||
The discovery of carboline analogs as potent MAPKAP-K2 inhibitors | Q27646039 | ||
ZINC--a free database of commercially available compounds for virtual screening | Q27656255 | ||
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 | ||
Navigating chemical space for biology and medicine | Q28298611 | ||
Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes | Q28728799 | ||
PubChem: a public information system for analyzing bioactivities of small molecules | Q28842768 | ||
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q28842973 | ||
The art and practice of structure-based drug design: A molecular modeling perspective | Q29029768 | ||
Targeting cancer with small molecule kinase inhibitors | Q29547395 | ||
Protein kinases--the major drug targets of the twenty-first century? | Q29615339 | ||
Extended-connectivity fingerprints | Q29616639 | ||
Charting biologically relevant chemical space: a structural classification of natural products (SCONP) | Q30351855 | ||
Drug-like properties and the causes of poor solubility and poor permeability | Q30660926 | ||
Recognizing molecules with drug-like properties | Q30741925 | ||
Prediction of 'drug-likeness'. | Q30829130 | ||
Pursuing the leadlikeness concept in pharmaceutical research. | Q30832332 | ||
Molecular properties that influence oral drug-like behavior. | Q30839493 | ||
Toward designing drug-like libraries: a novel computational approach for prediction of drug feasibility of compounds | Q30854470 | ||
Selection criteria for drug-like compounds | Q30901599 | ||
Data shaving: a focused screening approach | Q30914154 | ||
Chemography: the art of navigating in chemical space. | Q30986108 | ||
Simple selection criteria for drug-like chemical matter | Q30990966 | ||
Is there a difference between leads and drugs? A historical perspective | Q31017131 | ||
NIH Molecular Libraries Initiative | Q31127242 | ||
Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? | Q32032942 | ||
Approaches to target class combinatorial library design | Q33202900 | ||
The different strategies for designing GPCR and kinase targeted libraries | Q33206126 | ||
Focused combinatorial library design based on structural diversity, druglikeness and binding affinity score | Q33214748 | ||
Drug discovery in the kinase inhibitory field using the Nested Chemical Library technology. | Q33227714 | ||
Knowledge-based design of target-focused libraries using protein-ligand interaction constraints | Q33231891 | ||
A kinase-focused compound collection: compilation and screening strategy | Q33252499 | ||
A simple method to improve the odds in finding 'lead-like' compounds from chemical libraries | Q33289445 | ||
Lessons learnt from assembling screening libraries for drug discovery for neglected diseases | Q33309109 | ||
Kinase-likeness and kinase-privileged fragments: toward virtual polypharmacology | Q33320664 | ||
Kinase-targeted library design through the application of the PharmPrint methodology | Q33389288 | ||
Design, selection, and evaluation of a general kinase-focused library | Q33474002 | ||
Physiochemical property space distribution among human metabolites, drugs and toxins | Q33517179 | ||
The design, annotation, and application of a kinase-targeted library | Q33730358 | ||
Mining the ChEMBL database: an efficient chemoinformatics workflow for assembling an ion channel-focused screening library | Q34041986 | ||
Molecular properties that influence the oral bioavailability of drug candidates | Q34130727 | ||
Guiding molecules towards drug-likeness. | Q34798904 | ||
Current trends in lead discovery: are we looking for the appropriate properties? | Q35054077 | ||
ADMET in silico modelling: towards prediction paradise? | Q35075770 | ||
Profiling drug-like properties in discovery research | Q35162435 | ||
Automated selection of compounds with physicochemical properties to maximize bioavailability and druglikeness | Q35176797 | ||
Scaffold-based design of kinase inhibitors for cancer therapy | Q37636957 | ||
Protein kinases--structure and function. | Q40463748 | ||
Property-based design of GPCR-targeted library | Q44165334 | ||
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo | Q44280921 | ||
Predicting polypharmacology by binding site similarity: from kinases to the protein universe | Q45763650 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P304 | page(s) | 4 | |
P577 | publication date | 2012-02-08 | |
P1433 | published in | Journal of Cheminformatics | Q6294930 |
P1476 | title | A physicochemical descriptor-based scoring scheme for effective and rapid filtering of kinase-like chemical space | |
P478 | volume | 4 |
Q91205740 | A drug-likeness toolbox facilitates ADMET study in drug discovery |
Q49821776 | A physicochemical descriptor based method for effective and rapid screening of dual inhibitors against BACE-1 and GSK-3β as targets for Alzheimer's disease. |
Q92580402 | Application of Negative Design To Design a More Desirable Virtual Screening Library |
Q46317628 | Cheminformatic characterization of natural products from Panama |
Q66809436 | Dendrimer space concept for innovative nanomedicine: A futuristic vision for medicinal chemistry |
Q35031360 | DrugMint: a webserver for predicting and designing of drug-like molecules |
Q100666573 | HerbiPAD: a free web platform to comprehensively analyze constitutive property and herbicide-likeness to estimate chemical bioavailability |
Q87181220 | Identification of novel compounds for human bitter taste receptors |
Q90942309 | InsectiPAD: A Web Tool Dedicated to Exploring Physicochemical Properties and Evaluating Insecticide-Likeness of Small Molecules |
Q89836554 | Novel 1,3,4-oxadiazole thioether derivatives containing flexible-chain moiety: Design, synthesis, nematocidal activities, and pesticide-likeness analysis |
Search more.